Number of the records: 1  

rituximab

  1. Subject h.rituximab
    Subject h.Rituximab
    Entry termsCD20 protilátka, rituximab
    IDEC-C2B8 protilátka
    GP2013
    Scope note in EnglishA murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
    See also reference (FX) in Slovak antigény CD20
    See also reference (FX) in English Antigens, CD20
    Links (84) - ARTICLES
    (1) - MeSH descriptor
    (8) - CiBaMed
    (1) - ELECTRONIC RESOURCES
    (2) - BOOKS
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all